Page 19 - INFO agosto 2018

Implicações Clínicas das Mutações da Proteína Viral R na Progressão da Infeção por VIH Agosto2018 INFO

19. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. shuttle vector. J Virol 1999 Sep;73(9):7132-7.
The HIV-1 rev trans-activator acts through a structured 33. Henklein P, Bruns K, Sherman MP, Tessmer U, Li-
target sequence to activate nuclear export of unspliced cha K, Kopp J, et al. Functional and structural charac-
viral mRNA. Nature 1989 Mar 16;338(6212):254-7.
terization of synthetic HIV-1 Vpr that transduces cells,
20. Fanales-Belasio E, Raimondo M, Suligoi B, Butto S. localizes to the nucleus, and induces G2 cell cycle ar-
HIV virology and pathogenetic mechanisms of infection: rest. J Biol Chem 2000 Oct 13;275(41):32016-26.
a brief overview. Ann Ist Super Sanita 2010; 46(1):5-14. 34. Kogan M, Rappaport J. HIV-1 accessory protein
21. Haseltine WA. Replication and pathogenesis of Vpr: relevance in the pathogenesis of HIV and potential
the AIDS virus. J Acquir Immune Defc Syndr 1988; for therapeutic intervention. Retrovirology 2011;8:25.
1(3):217-40. 35. Bachand F, Yao XJ, Hrimech M, Rougeau N, Co-
22. Tristem M, Marshall C, Karpas A, Hill F. Evolution hen EA. Incorporation of Vpr into human immunode-
of the primate lentiviruses: evidence from vpx and vpr. fciency virus type 1 requires a direct interaction with
EMBO J 1992 Sep;11(9):3405-12. the p6 domain of the p55 gag precursor. J Biol Chem
1999 Mar 26;274(13):9083-91.
23. Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski
JG, Haseltine WA. Identifcation of HIV-1 vpr product and 36. Singh SP, Tomkowicz B, Lai D, Cartas M, Maha-
function. J Acquir Immune Defc Syndr 1990; 3(1):11-8. lingam S, Kalyanaraman VS, et al. Functional role of
residues corresponding to helical domain II (amino
24. Yuan X, Matsuda Z, Matsuda M, Essex M, Lee TH.
Human immunodefciency virus vpr gene encodes a acids 35 to 46) of human immunodefciency virus type
virion-associated protein. AIDS Res Hum Retroviruses 1 Vpr. J Virol 2000 Nov;74(22):10650-7.
1990 Nov;6(11):1265-71. 37. Jenkins Y, Sanchez PV, Meyer BE, Malim MH. Nu-
25. Sawaya BE, Khalili K, Gordon J, Taube R, Amini S. Co- clear export of human immunodefciency virus type 1
operative interaction between HIV-1 regulatory proteins Vpr is not required for virion packaging. J Virol 2001
Tat and Vpr modulates transcription of the viral genome. Sep;75(17):8348-52.
J Biol Chem 2000 Nov 10;275(45):35209-14. 38. Kondo E, Gottlinger HG. A conserved LXXLF se-
26. Romani B, Engelbrecht S. Human immunodef- quence is the major determinant in p6gag required
ciency virus type 1 Vpr: functions and molecular inte- for the incorporation of human immunodefciency vi-
ractions. J Gen Virol 2009 Aug;90(Pt 8):1795-805. rus type 1 Vpr. J Virol 1996 Jan;70(1):159-64.
39. Muller B, Tessmer U, Schubert U, Krausslich HG.
27. Sorgel S, Fraedrich K, Votteler J, Thomas M, Stam- Human immunodefciency virus type 1 Vpr protein is
minger T, Schubert U. Perinuclear localization of the incorporated into the virion in signifcantly smaller
HIV-1 regulatory protein Vpr is important for induction amounts than gag and is phosphorylated in infected
of G2-arrest. Virology 2012 Oct 25;432(2):444-51.
cells. J Virol 2000 Oct;74(20):9727-31.
28. Chang F, Re F, Sebastian S, Sazer S, Luban J.
HIV-1 Vpr induces defects in mitosis, cytokinesis, nu- 40. Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Se-
clear structure, and centrosomes. Mol Biol Cell 2004 rum Vpr regulates productive infection and latency of
Apr;15(4):1793-801. human immunodefciency virus type 1. Proc Natl Acad
Sci U S A 1994 Nov 8;91(23):10873-7.
29. Roshal M, Zhu Y, Planelles V. Apoptosis in AIDS.
Apoptosis 2001 Feb;6(1-2):103-16. 41. Wheeler ED, Achim CL, Ayyavoo V. Immunodetec-
tion of human immunodefciency virus type 1 (HIV-1)
30. Vodicka MA, Koepp DM, Silver PA, Emerman M. Vpr in brain tissue of HIV-1 encephalitic patients. J
HIV-1 Vpr interacts with the nuclear transport pathway Neurovirol 2006 Jun;12(3):200-10.
to promote macrophage infection. Genes Dev 1998
Jan 15;12(2):175-85. 42. Sabbah EN, Roques BP. Critical implication of the
(70-96) domain of human immunodefciency virus type
31. Rogel ME, Wu LI, Emerman M. The human immuno- 1 Vpr protein in apoptosis of primary rat cortical and
defciency virus type 1 vpr gene prevents cell proliferation striatal neurons. J Neurovirol 2005 Dec;11(6):489-502.
during chronic infection. J Virol 1995 Feb;69 (2):882-8.
43. Kitayama H, Miura Y, Ando Y, Hoshino S, Ishizaka Y,
32. Jowett JB, Xie YM, Chen IS. The presence of human Koyanagi Y. Human immunodefciency virus type 1 Vpr
immunodefciency virus type 1 Vpr correlates with a inhibits axonal outgrowth through induction of mitochon-
decrease in the frequency of mutations in a plasmid drial dysfunction. J Virol 2008 Mar;82(5):2528-42.

19